Monitoring Treatment Response
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Monitoring Treatment Response
-
Narrated by:
-
Written by:
About this listen
Kari Magee speaks with Dr Bethany Verkamp to discuss her recent research on evaluating treatment response to etoposide-based treatment in patients with HLH. Dr Verkamp is a hematology/oncology fellow in the Cancer and Blood Diseases Institute at Cincinnati Children's Hospital. Hear from Dr Verkamp about her research, findings, and important considerations for assessing patient response to first-line etoposide-based HLH therapy.
Follow Us
- YouTube @Sobi-Pharma
- Linkedin @Sobi
Presented by Sobi Inc.
https://www.sobi.com/usa/en
©2023 Sobi, Inc. All rights reserved. NP-32204 12/23
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
No reviews yet